Sustainable Influenza Vaccine Production Capacity Stakeholders' Workshop: Day 1 Agenda
January 11, 2010 - Washington, D.C.
Agenda: DAY 1 | DAY 2 | DAY 3
| 7:00 am – 8:30 am Ballroom Foyer | Continental Breakfast and Workshop Registration | |
| 8:30 am – 8:40 am Ballroom | Opening Remarks Dr. Nicole Lurie Assistant Secretary for Preparedness and Response Rear Admiral, U.S. Public Health Service U.S. Department of Health and Human Services Introduction by: Dr. Michael L. Perdue Director, Division of Influenza and Emerging Diseases Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services | |
| 8:40 am – 8:50 am Ballroom | Welcome and Introduction to the Objectives of the Meeting Workshop Co-Chairs | |
| 8:50 am – 9:20 am Ballroom | Keynote Address: Global Response to the H1N1 Pandemic Dr. Marie-Paule Kieny Director, Initiative for Vaccine Research World Health Organization Introduction by: Mr. John T. Monahan Interim Director, Office of Global Health Affairs and Counselor to the Secretary U.S. Department of Health and Human Services | |
| 9:20 am – 10:00 am Ballroom | Overview of Current Vaccine Manufacturing Capacity in Developing Countries: Existing Infrastructure Moderator Mr. John T. Monahan Interim Director, Office of Global Health Affairs and Counselor to the Secretary U.S. Department of Health and Human Services Speakers | |
| 9:20 am – 9:35 am | Dr. Marie-Paule Kieny Director, Initiative for Vaccine Research World Health Organization | |
| 9:35 am – 9:50 am | Dr. Suresh Jadhav Ex-President - Developing Countries Vaccine Manufacturers Network Executive Director – Serum Institute of India Ltd./Pune | |
| 9:50 am – 10:00 am | Discussion | |
| 10:00 am – 10:30 am | Tea Break | |
| 10:30 am – 11:25 am Ballroom | Overview of Existing Efforts to Develop Sustainable Vaccine Manufacturing Capacity in Developing Countries Moderator Dr. Samuel Ponce de León General Director of the Biological and Reactive Laboratories of Mexico Speakers | |
| 10:30 am –10:45 am | Ms. Christina M. Hartman Project Officer for International Cooperative Agreements Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services | |
| 10:45 am – 11:00 am | Dr. Laszlo Palkonyay Project Officer for HHS Cooperative Agreement World Health Organization | |
| 11:00 am – 11:15 am | Dr. Rick Bright Scientific Director, Influenza Vaccine Project Vaccine Development Global Program PATH | |
| 11:15 am - 11:25 am | Discussion | |
| 11:25 am – 12:45 pm Ballroom | Technical Considerations: Role of New and Existing Technologies and Adjuvants and Technology Transfer Models Moderator Dr. Mark L. Rohrbaugh Director, Office of Technology Transfer Office of Intramural Research Office of the Director National Institutes of Health U.S. Department of Health and Human Services Speakers | |
| 11:25 am – 11:40 am | Dr. Robin Robinson Director, Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response U .S. Department of Health and Human Services | |
| 11:40 am – 11:55 am | Dr. Armen Donabedian Senior Program Manager, Division of Influenza and Emerging Diseases Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services | |
| 11:55 am – 12:10 pm | Dr. Douglas Holtzman Senior Program Officer Bill & Melinda Gates Foundation | |
| 12:10 pm – 12:25 pm | Dr. Jan Hendriks Account Manager, International Support The Netherlands Vaccine Institute | |
| 12:25 pm – 12:45 pm | Discussion | |
| 12:45 pm – 1:45 pm Solarium | Lunch | |
| 1:45 pm – 2:30 pm Ballroom | Technical Considerations: Defining Manufacturing Standards, Regulatory Needs, and Capacity and Role of Clinical Trials Moderator Dr. Jesse Goodman Chief Scientist and Deputy Commissioner for Science and Public Health (Acting) U.S. Food and Drug Administration U.S. Department of Health and Human Services Speakers | |
| 1:45 pm – 2:00 pm | Dr. David Wood Coordinator, Quality Safety and Standards, Immunizations Vaccines and Biologicals World Health Organization | |
| 2:00 pm – 2:15 pm | Dr. Vu Minh Huong Senior Program Team Leader PATH Vietnam Office | |
| 2:15 pm – 2:30 pm | Discussion | |
| 2:30 pm – 3:00 pm Ballroom Foyer | Tea Break | |
| 3:00 pm – 4:00 pm Ballroom | Cost Considerations: Ensuring the Best Returns on Investment while Ensuring Sustainability and Diversification Moderator and Speaker | |
| 3:00 pm – 3:15 pm | Dr. Barry Bloom Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health Department of Immunology and Infectious Diseases Harvard School of Public Health Speakers | |
| 3:15 pm – 3:30 pm | Dr. Vichai Chokevivat Chairman of the Board Thai Government Pharmaceutical Organization | |
| 3:30 pm – 4:00 pm | Discussion | |
| 4:00 pm – 5:00 pm Ballroom | Discussion and Final Comments from Day 1 Moderators Workshop Co-Chairs | |
| 5:00 pm – 6:30 pm Solarium | Welcome Reception | |
